TimesSquare Capital Management LLC Acquires 6,490 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

TimesSquare Capital Management LLC increased its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 2.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 276,915 shares of the company's stock after acquiring an additional 6,490 shares during the quarter. TimesSquare Capital Management LLC owned about 1.53% of Addus HomeCare worth $36,838,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in ADUS. Assetmark Inc. increased its holdings in shares of Addus HomeCare by 11.5% in the third quarter. Assetmark Inc. now owns 1,169 shares of the company's stock valued at $156,000 after purchasing an additional 121 shares during the last quarter. Equitable Trust Co. raised its holdings in Addus HomeCare by 2.2% in the 3rd quarter. Equitable Trust Co. now owns 4,825 shares of the company's stock valued at $642,000 after acquiring an additional 106 shares during the period. Principal Financial Group Inc. lifted its position in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after acquiring an additional 75,409 shares during the last quarter. Robeco Institutional Asset Management B.V. bought a new stake in shares of Addus HomeCare during the third quarter worth approximately $414,000. Finally, Harbor Capital Advisors Inc. increased its stake in shares of Addus HomeCare by 127.7% during the third quarter. Harbor Capital Advisors Inc. now owns 64,311 shares of the company's stock worth $8,555,000 after purchasing an additional 36,071 shares during the period. Institutional investors own 95.35% of the company's stock.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares of the company's stock, valued at $961,687.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, Director Esteban Lopez sold 500 shares of the firm's stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company's stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 in the last 90 days. 4.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have commented on ADUS. KeyCorp assumed coverage on Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective on the stock. TD Cowen raised their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a research report on Thursday, August 8th. Royal Bank of Canada cut their price objective on shares of Addus HomeCare from $141.00 to $136.00 and set an "outperform" rating for the company in a report on Wednesday. Macquarie restated an "outperform" rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Oppenheimer lifted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research report on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $131.63.

Addus HomeCare Stock Down 1.2 %

Shares of ADUS traded down $1.50 during midday trading on Friday, hitting $127.58. The company's stock had a trading volume of 140,597 shares, compared to its average volume of 126,492. The company's fifty day simple moving average is $129.60 and its two-hundred day simple moving average is $121.40. The stock has a market capitalization of $2.31 billion, a price-to-earnings ratio of 29.19, a price-to-earnings-growth ratio of 2.30 and a beta of 1.04. Addus HomeCare Co. has a one year low of $81.51 and a one year high of $136.12.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm's revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.03 EPS. On average, research analysts predict that Addus HomeCare Co. will post 4.57 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.